RELMADA THERAPEUTICS
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada' s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 has entered late-stage development as an adjunctive treatment for MDD in adults.()
RELMADA THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.relmada.com
Total Employee:
11+
Status:
Active
Contact:
646-876-3459
Email Addresses:
[email protected]
Total Funding:
183.13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache Global Site Tag
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Stock Details
Investors List
BioAdvance
BioAdvance investment in Post-IPO Equity - Relmada Therapeutics
BioAdvance
BioAdvance investment in Venture Round - Relmada Therapeutics
BioAdvance
BioAdvance investment in Series A - Relmada Therapeutics
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Series A - Relmada Therapeutics
BioAdvance
BioAdvance investment in Seed Round - Relmada Therapeutics
Official Site Inspections
http://www.relmada.com Semrush global rank: 1.06 M Semrush visits lastest month: 31.66 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
